Tesamorelin comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-03-14. Where a claim depends on a specific study, the study is described rather than over-claimed.
Tesamorelin is a synthetic peptide that belongs to the growth hormone-releasing hormone family and contains the same forty-four amino acid sequence as endogenous GHRH, extended at the amino terminus by a trans-3-hexenoyl group. That small fatty acid modification protects the peptide from rapid cleavage by dipeptidyl peptidase-4, the enzyme that shortens the half-life of native GHRH to only a few minutes. Chemically the compound is produced by solid-phase peptide synthesis, purified by chromatography, and supplied as a sterile lyophilized powder for reconstitution.
Regulatory approval in the United States came in 2010, when the Food and Drug Administration cleared the peptide for the reduction of excess abdominal fat in adults with HIV infection and associated lipodystrophy. The decision rested mainly on two randomized phase 3 trials that enrolled roughly eight hundred patients and ran for twenty-six weeks. Participants receiving active drug showed substantially greater declines in visceral adipose tissue than those receiving placebo, while total body weight changed comparatively little. A reformulated presentation was later approved, and the product has remained a niche therapy rather than a general weight-loss agent.
Signaling begins at the GHRH receptor, a class B G protein-coupled receptor displayed on somatotroph cells of the anterior pituitary. Receptor occupancy activates Gs proteins, which raise adenylyl cyclase activity and intracellular cyclic AMP, in turn driving protein kinase A dependent pathways. The downstream output is synthesis and pulsatile secretion of growth hormone into the bloodstream. Hepatic tissue and peripheral sites respond by increasing insulin-like growth factor 1 production. Somatostatin and IGF-1 itself supply negative feedback that caps the size and duration of each secretory burst.
Metabolic interest in this compound centers on fat distribution rather than on hormone levels alone. Imaging trials in adults with excess abdominal fat report reductions in visceral adipose tissue, while subcutaneous depots change comparatively little. Growth hormone and IGF-1 are presumed to carry the effect, but the separate contribution of each is not firmly established. Whether these changes persist after treatment stops, and whether they alter longer-term health outcomes, remain open questions that published work does not answer consistently.
Tesamorelin is a synthetic peptide of forty-four amino acids whose sequence reproduces human growth hormone-releasing hormone. Its distinguishing feature sits at the amino terminus, where a trans-3-hexenoyl group replaces the free amine. That acylation slows cleavage by dipeptidyl peptidase IV, an enzyme that otherwise removes the first two residues and inactivates the natural hormone quickly. The modified peptide therefore persists longer in circulation while keeping the same receptor target. It is handled as a lyophilized solid and dissolved shortly before use.
| Property | Value | Notes |
|---|---|---|
| Peptide class | Synthetic GHRH analogue | 44 residues; N-terminal trans-3-hexenoyl group |
| First approval year | 2010 | United States; HIV-associated abdominal fat accumulation |
| Administration route | Subcutaneous injection | Abdominal site; clinician-administered or self-injected |
| Common synonyms | TH9507; tesamorelin acetate | Development code and acetate salt form |
| Originator | Canadian biotechnology firm | Original developer and regulatory sponsor |
Tesamorelin is a synthetic peptide that belongs to the growth hormone-releasing hormone (GHRH) family. Its sequence corresponds to the fully active 44-amino-acid form of human GHRH, with a single structural modification: the addition of a trans-3-hexenoyl group at the N-terminus. That modification is not found in the naturally occurring hormone and was introduced deliberately during development to improve stability against enzymatic degradation. The compound is therefore best described as a stabilized analogue rather than a naturally occurring peptide.
The native hormone is produced in the hypothalamus and acts on the anterior pituitary. Binding of GHRH to its receptor stimulates synthesis and release of growth hormone into circulation. Because the analogue retains the receptor-binding region of the parent sequence, it engages the same receptor and triggers the same downstream signaling. The result is increased growth hormone secretion from pituitary cells, which in turn influences hepatic production of insulin-like growth factor 1. This axis is the basis for the compound's measured biological effects.
Interest in this peptide developed because native GHRH has a short circulating lifetime. The N-terminal modification slows cleavage by dipeptidyl peptidase IV, an enzyme that removes the first two residues of many peptides and terminates their activity. Slower degradation means a longer window of receptor stimulation per administration. This design logic parallels other modified peptide hormones, where a small chemical change at a vulnerable site yields a more durable molecule without altering the core mechanism of action.
The actual preparation of the brew takes several hours, often taking place over the course of more than one day. After adding the plant material, each separately at this stage, to a large pot of water, it is boiled until the water is reduced by half in volume. The individual brews are then combined and brewed until reduced significantly, producing the form taken by participants in ayahuasca ceremonies.
== UK appliance safety recalls == Following its 2014 acquisition of Indesit, Whirlpool identified a fire risk affecting certain vented and condensing tumble dryers sold in the United Kingdom under the Hotpoint, Indesit, Creda, Swan and Proline brands. The affected models had been manufactured between April 2004 and September 2015; lint could accumulate and come into contact with a heating element, creating a fire risk. Whirlpool told the House of Commons Business, Energy and Industrial Strategy Committee that 5.3 million affected machines had been manufactured for the UK market. Whirlpool began a modification programme in November 2015 rather than a full recall. Owners were initially advised that affected dryers could continue to be used under specified precautions, but the advice was changed in early 2017 to tell consumers not to use unmodified machines. In August 2016, a fire at Shepherds Court in Shepherd's Bush was attributed by the London Fire Brigade to an Indesit tumble dryer covered by Whirlpool's corrective-action programme. A House of Commons committee later criticised the decision not to initiate a full recall and the pace of the modification programme. In April 2019, the Office for Product Safety and Standards (OPSS) concluded that the risk of harm or injury from lint fires in dryers that had been modified was low, but required Whirlpool to improve aspects of its risk management and communication with consumers. Following further intervention by OPSS, Whirlpool agreed in July 2019 to recall remaining unmodified affected tumble dryers.
=== Complications === GDM poses a risk to the mother and child. This risk is largely related to uncontrolled blood glucose levels and their consequences. The risk increases with higher blood glucose levels. Treatment resulting in better control of these levels can reduce some of the risks of GDM considerably. Having GDM can lead to mental health issues, with the distress added to the pregnancy. Women with gestational diabetes experienced increased anxiety, depression, and stress. Not only does it affect mental health during pregnancy, but it also leads to an increased risk of postpartum depression. The risk is over 4 times greater than a normal pregnancy. It was found that physical activity could decrease the risk of postpartum depression. It is a form of therapy that can help reduce the stress of these mental health issues. The two main risks GDM imposes on the baby are growth abnormalities and chemical imbalances after birth, which may require admission to a neonatal intensive care unit. Infants born to mothers with GDM are at risk of being both large for gestational age (macrosomic) in unmanaged GDM, and small for gestational age and Intrauterine growth retardation in managed GDM. Macrosomia in turn increases the risk of instrumental deliveries (e.g., forceps, ventouse, and caesarean section) or problems during vaginal delivery (such as shoulder dystocia). Macrosomia may affect 12% of normal women compared to 20% of women with GDM.
Changes in actin's folding occur in nemaline myopathy as well as changes in its aggregation and there are also changes in the expression of other associated proteins. In some variants where intranuclear bodies are found the changes in the folding masks the nucleus's protein exportation signal so that the accumulation of actin's mutated form occurs in the cell nucleus. On the other hand, it appears that mutations to ACTA1 that give rise to a CFTDM have a greater effect on sarcomeric function than on its structure. Recent investigations have tried to understand this apparent paradox, which suggests there is no clear correlation between the number of rods and muscular weakness. It appears that some mutations are able to induce a greater apoptosis rate in type II muscular fibres.
Sources: en.wikipedia.org
Using this technique the resolution of deuterium exchange is determined by the size of the peptides produced during digestion. Pepsin, an acid protease, is commonly used for proteolysis, as the quench pH must be maintained during the proteolytic reaction. To minimize the back-exchange, proteolysis and subsequent mass spectrometry analysis must be done as quickly as possible. HPLC separation of the peptic digest is often carried out at low temperature just prior to electrospray mass spectrometry to minimize back-exchange. More recently, UPLC has been used due to its superior separation capabilities. It was proposed in 1999 that it might be possible to achieve single-residue resolution by using collision-induced dissociation (CID) fragmentation of deuterated peptides in conjunction with tandem mass spectrometry. It was soon discovered that CID causes "scrambling" of the deuterium position within the peptides. However, fragmentation produced by MALDI in-source decay (ISD), electron capture dissociation (ECD), and electron transfer dissociation (ETD) proceed with little or no scrambling under the correct experimental conditions. Scrambling of the isotopic labeling is caused by collisional heating prior to dissociation of the ion and while CID do cause scrambling, collisional heating can also occur during ionization and ion transport.
is the dosing interval, ss means steady state and 1 stands for a single-dose application. Another definition sets Rac to the ratio of the average drug concentration during one day under steady state conditions to the concentration after a single dose.
House of Representatives votes 222–208 to censure Rep. Paul Gosar (R–AZ) after he posted a photo-shopped anime clip of him killing Rep. Alexandria Ocasio-Cortez (D–NY) and threatening President Biden, making him the first lawmaker to be censured since Charlie Rangel in 2010. November 19 Vice President Harris serves as acting president from 10:10 am to 11:35 am EST, while President Biden undergoes a colonoscopy under anesthesia. The U.S. House of Representatives votes 220–213 to pass the Build Back Better Act, a US$1.75 trillion social and climate spending package. State of Wisconsin v Kyle Rittenhouse: Mr. Rittenhouse is found not guilty on five charges of attempted murder, after three weeks of debate, and three days of jury deliberation. November 21 – Waukesha Christmas parade attack: An SUV is driven through the annual Christmas parade in Waukesha, Wisconsin, killing six people and injuring 62 others. The alleged driver of the vehicle, 39-year-old Darrell E. Brooks, is arrested and charged with five counts of murder. November 23 – The Biden administration announces a release of 50 million oil barrels from the Strategic Petroleum Reserve to bring down inflation in conjunction with other countries' efforts, the largest release in history. An investigation into oil companies' practices is also announced. November 24 NASA launches the Double Asteroid Redirection Test (DART), the first attempt to deflect an asteroid for the purpose of learning how to protect Earth. All three defendants are found guilty of the murder of Ahmaud Arbery.
=== ConSurf === Ben-Tal has led the development of ConSurf, a computational method and web server that uses evolutionary information to identify potentially functionally important regions in proteins. The methodology maps evolutionary conservation scores onto three-dimensional molecular structures, allowing conserved regions of a protein to be visualized on its surface. The original ConSurf work was published in Bioinformatics in 2003 by a team that included Ben-Tal, Fabian Glaser, Tal Pupko, Inbal Paz, Rachel E. Bell, Dalit Bechor-Shental, and Eric Martz. The ConSurf project has subsequently been expanded through successive versions and databases. A 2016 paper described an updated methodology for estimating and visualizing evolutionary conservation in macromolecules, while later work produced ConSurf-DB, a repository containing precomputed evolutionary conservation profiles for proteins with known structures. Ben-Tal has continued to contribute to the development of ConSurf. A 2023 paper described a revised version of the system for using evolutionary information to analyze macromolecules.
Biopanning is an affinity selection technique which selects for peptides that bind to a given target. All peptide sequences obtained from biopanning using combinatorial peptide libraries have been stored in a special freely available database named BDB. This technique is often used for the selection of antibodies too. Biopanning involves 4 major steps for peptide selection. The first step is to have phage display libraries prepared. This involves inserting foreign desired gene segments into a region of the bacteriophage genome, so that the peptide product will be displayed on the surface of the bacteriophage virion. The most often used are genes pIII or pVIII of bacteriophage M13. The next step is the capturing step. It involves conjugating the phage library to the desired target. This procedure is termed panning. It utilizes the binding interactions so that only specific peptides presented by bacteriophage are bound to the target. For example, selecting antibody presented by bacteriophage with coated antigen in microtiter plates. The washing step comes after the capturing step to wash away the unbound phages from solid surface. Only the bound phages with strong affinity are kept. The final step involves the elution step where the bound phages are eluted through changing of pH or other environment conditions. The result is the peptides produced by bacteriophage are specific. The resulting filamentous phages can infect gram-negative bacteria once again to produce phage libraries. The cycle can occur many times resulting with strong affinity binding peptides to the target.
Sources: en.wikipedia.org
It is a laboratory-made peptide of forty-four amino acids whose sequence matches human growth hormone-releasing hormone, with a modified amino terminus. The modification is a short unsaturated fatty acid chain attached to the first residue. This change slows enzymatic breakdown and lengthens the time the peptide stays active in circulation.
The clinical program was designed around HIV-associated lipodystrophy, a condition in which fat accumulates abnormally around the internal organs. Trials enrolled that specific population, so the evidence base covers it rather than the general population. Regulators approved the drug for the studied indication only, and promotion outside it is not permitted.
Growth hormone therapy supplies the finished hormone directly, while this peptide acts upstream and asks the pituitary to secrete its own. That difference means the response depends on a functioning pituitary and on the body's normal feedback loops. It also means the circulating hormone profile is pulsatile rather than a flat, injected level.
The amino acid sequence matches human growth hormone-releasing hormone, but the amino terminus carries a trans-3-hexenoyl group instead of a free amine. That single structural change chiefly affects enzymatic stability rather than receptor selectivity.